Peter W. Collins, MD

Professor of Haematology
Arthur Bloom Haemophilia Centre, School of Medicine, Cardiff University Hospital, Cardiff, United Kingdom

Peter Collins is a professor of haematology at Cardiff University and an honorary consultant haematologist at Cardiff and Vale University Health Board. He specialises in the management of acquired and congenital bleeding disorders through the Cardiff Haemophilia Centre and co-chiars the UKHCDO Data Analysis Group. His research interests include prophylaxis in haemophilia and the role of pharmacokinetics to individualise treatment, acquired haemophilia and factor VIII inhibitors. He has investigated the coagulopathy associated with bleeding after childbirth with a focus on point of care testing and fibrinogen replacement, co-leading a number of studies in the field. He has contributed to guidelines on the managemenr of postpartum haemorrhage. His basic science research covers the role of phospholipid membranes in the control of haemostasis nad their effect on bleeding and thrombotic diseases.

Presentation(s):

• OC 30.1 - Emicizumab prophylaxis in people with severe haemophilia A without inhibitors: outcomes from the UK Haemophilia Centre Doctors' Organisation

  Monday, July 11, 2022
  10:45 AM – 11:00 AM

• MC 11.1 - Modern Hemostatic Management of Obstetric Hemorrhage

  Monday, July 11, 2022
  1:15 PM – 2:00 PM

• OC 63.4 - Little discrepancy of one-stage and chromogenic assays in a large international cohort of patients with non-severe hemophilia A and B (DYNAMO study)

  Tuesday, July 12, 2022
  3:30 PM – 3:45 PM